2013 Q3 Form 10-Q Financial Statement

#000110465913059323 Filed on August 02, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q2
Revenue $629.0K $1.152M $923.0K
YoY Change -6.68% 24.81% 383.25%
Cost Of Revenue $459.0K $1.196M $437.0K
YoY Change 45.25% 173.68%
Gross Profit $170.0K -$44.00K $486.0K
YoY Change -52.51% -109.05% 155.79%
Gross Profit Margin 27.03% -3.82% 52.65%
Selling, General & Admin $2.995M $3.422M $3.437M
YoY Change -5.52% -0.44% -18.09%
% of Gross Profit 1761.76% 707.2%
Research & Development $4.520M $4.830M $5.010M
YoY Change -8.32% -3.59% -16.5%
% of Gross Profit 2658.82% 1030.86%
Depreciation & Amortization $210.0K $230.0K $340.0K
YoY Change -32.26% -32.35% -12.82%
% of Gross Profit 123.53% 69.96%
Operating Expenses $2.995M $3.422M $3.437M
YoY Change -5.52% -0.44% -18.09%
Operating Profit -$6.498M -$7.348M -$7.957M
YoY Change -16.08% -7.65% -20.47%
Interest Expense $40.00K $12.00K $34.00K
YoY Change 48.15% -64.71% 47.83%
% of Operating Profit
Other Income/Expense, Net -$9.000K -$9.000K $9.000K
YoY Change 350.0% -200.0%
Pretax Income -$6.720M -$7.090M -$7.950M
YoY Change -13.29% -10.82% -20.34%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$7.250M -$7.870M -$7.950M
YoY Change -6.45% -1.01% -20.34%
Net Earnings / Revenue -1152.62% -683.16% -861.32%
Basic Earnings Per Share -$0.21 -$0.23 -$0.23
Diluted Earnings Per Share -$0.21 -$0.23 -$0.23
COMMON SHARES
Basic Shares Outstanding 34.52M shares 34.43M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.70M $31.70M $48.20M
YoY Change -46.23% -34.23% -36.99%
Cash & Equivalents $8.872M $11.91M $12.13M
Short-Term Investments $16.90M $19.80M $36.00M
Other Short-Term Assets $900.0K $900.0K $600.0K
YoY Change 28.57% 50.0% 0.0%
Inventory $3.400M $3.196M $2.821M
Prepaid Expenses
Receivables $501.0K $336.0K $1.000M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $30.94M $36.91M $52.60M
YoY Change -41.48% -29.82% -32.3%
LONG-TERM ASSETS
Property, Plant & Equipment $891.0K $1.087M $1.800M
YoY Change -45.47% -39.61% -28.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $11.80M
YoY Change -100.0% -36.9%
Other Assets $50.00K $95.00K $700.0K
YoY Change -47.37% -86.43% 0.0%
Total Long-Term Assets $1.560M $1.801M $14.33M
YoY Change -80.72% -87.43% -34.25%
TOTAL ASSETS
Total Short-Term Assets $30.94M $36.91M $52.60M
Total Long-Term Assets $1.560M $1.801M $14.33M
Total Assets $32.50M $38.71M $66.93M
YoY Change -46.69% -42.16% -32.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $422.0K $102.0K $600.0K
YoY Change 75.83% -83.0% 0.0%
Accrued Expenses $3.190M $3.211M $2.926M
YoY Change -8.86% 9.74% -13.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.300M $3.980M $4.000M
YoY Change -11.38% -0.5% -35.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $137.0K $300.0K
YoY Change -100.0% -54.33% -99.19%
Total Long-Term Liabilities $0.00 $137.0K $300.0K
YoY Change -100.0% -54.33% -99.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.300M $3.980M $4.000M
Total Long-Term Liabilities $0.00 $137.0K $300.0K
Total Liabilities $4.300M $4.117M $4.262M
YoY Change -15.3% -3.4% -90.16%
SHAREHOLDERS EQUITY
Retained Earnings -$263.9M -$256.7M
YoY Change 13.5%
Common Stock $292.2M $291.3M
YoY Change 1.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.20M $34.60M $62.67M
YoY Change
Total Liabilities & Shareholders Equity $32.50M $38.71M $66.93M
YoY Change -46.69% -42.16% -32.73%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$7.250M -$7.870M -$7.950M
YoY Change -6.45% -1.01% -20.34%
Depreciation, Depletion And Amortization $210.0K $230.0K $340.0K
YoY Change -32.26% -32.35% -12.82%
Cash From Operating Activities -$5.920M -$5.790M -$5.880M
YoY Change -5.73% -1.53% -1.01%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$210.0K -$140.0K
YoY Change -90.91% 50.0% -17.65%
Acquisitions
YoY Change
Other Investing Activities $2.900M -$2.610M $8.550M
YoY Change -75.13% -130.53% -119.65%
Cash From Investing Activities $2.890M -$2.810M $8.420M
YoY Change -74.98% -133.37% -119.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 10.00K
YoY Change -100.0% -99.98%
NET CHANGE
Cash From Operating Activities -5.920M -5.790M -5.880M
Cash From Investing Activities 2.890M -2.810M 8.420M
Cash From Financing Activities 0.000 0.000 10.00K
Net Change In Cash -3.030M -8.600M 2.550M
YoY Change -157.5% -437.25% -1044.44%
FREE CASH FLOW
Cash From Operating Activities -$5.920M -$5.790M -$5.880M
Capital Expenditures -$10.00K -$210.0K -$140.0K
Free Cash Flow -$5.910M -$5.580M -$5.740M
YoY Change -4.21% -2.79% -0.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Investments And Cash
InvestmentsAndCash
31678000 USD
mblx Minimum Period For Which Cash Cash Equivalents Investments And Cash From Expected Product Sales Is Sufficient To Meet Projected Operating Requirements
MinimumPeriodForWhichCashCashEquivalentsInvestmentsAndCashFromExpectedProductSalesIsSufficientToMeetProjectedOperatingRequirements
P12M
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 26pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></p> <p style="TEXT-INDENT: 26pt; MARGIN: 0in 0in 0pt;">&#160;</p> </div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Concentration of Credit Risk</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 27pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash and cash equivalents and short-term investments. The Company primarily invests its excess cash and cash equivalents in money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments are acquired in accordance with the Company&#8217;s investment policy which establishes a concentration limit per issuer.</font></p> <p style="TEXT-INDENT: 27pt; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 27pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company provides credit to customers in the normal course of business. The Company performs ongoing credit evaluations of its customers&#8217; financial condition and limits the amount of credit extended when deemed necessary. At June&#160;30, 2013, the Company&#8217;s accounts and unbilled receivables include $724 or 63% from U.S. and Canadian government grants and $315 or 27% from customer product sales. At December&#160;31, 2012, the Company&#8217;s accounts and unbilled receivables included $561 or 46% from U.S. and Canadian government grants and $535 or 44% from customer product sales. At June&#160;30, 2013, no customer had accounts receivable due from product sales of 10% or greater, and December&#160;31, 2012, one customer represented 41%, of accounts receivable due from product sales.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> </div>
us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7866000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7948000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14628000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20892000 USD
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34434271 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34393998 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
104410 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
104410 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34264428 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5647604 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4460713 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5539962 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4440713 shares
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
674000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2522000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
3196000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
640000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2562000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
3204000 USD
CY2013Q2 us-gaap Deferred Revenue
DeferredRevenue
163000 USD
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
257000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
31696000 USD
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
13000 USD
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
31709000 USD
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
19768000 USD
CY2013Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
3000 USD
CY2013Q2 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
19770000 USD
mblx Long Term Investments Maximum Maturity Period
LongTermInvestmentsMaximumMaturityPeriod
P2Y
mblx Available For Sale Securities Average Maturity
AvailableForSaleSecuritiesAverageMaturity
P3M
CY2012 mblx Available For Sale Securities Average Maturity
AvailableForSaleSecuritiesAverageMaturity
P4M
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1695000 USD
CY2013Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
436000 USD
CY2013Q2 mblx Accrued Intellectual Property Current
AccruedIntellectualPropertyCurrent
163000 USD
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
917000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3211000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2379000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
301000 USD
CY2012Q4 mblx Accrued Intellectual Property Current
AccruedIntellectualPropertyCurrent
105000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
734000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3519000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Inventory Write Down
InventoryWriteDown
271000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 item
us-gaap Sales Revenue Net
SalesRevenueNet
3648000 USD
us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
3648000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1706000 USD
CY2013Q2 us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
1706000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
923000 USD
CY2012Q2 us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
923000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
40245000 USD
us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
40245000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
814000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1677000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
980000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2102000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4714000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5579042 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6173843 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
903915 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7550 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
127693 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
173871 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3458023 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.68
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.91
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.67
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.82
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.69
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.09
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.28
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.18
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0071 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0067 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0149 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0115 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.84 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.85 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.87 pure
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1358000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1087000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2012Q4 mblx Operating Loss Carryforwards Attributable To Deduction Related To Exercise Of Stock Options
OperatingLossCarryforwardsAttributableToDeductionRelatedToExerciseOfStockOptions
19213000 USD
mblx Maximum Period To Audit For Loss
MaximumPeriodToAuditForLoss
P3Y
mblx Provision For Income Taxes For Undistributed Earnings Of Foreign Subsidiaries
ProvisionForIncomeTaxesForUndistributedEarningsOfForeignSubsidiaries
0 USD
CY2012Q4 us-gaap Assets
Assets
53510000 USD
mblx Revenue From Termination Of Collaboration With Subsidiary
RevenueFromTerminationOfCollaborationWithSubsidiary
38885000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14572000 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
29201000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
839000 USD
CY2012Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
75000 USD
CY2012Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
372000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
692000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
48955000 USD
CY2012Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
252000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
0 USD
us-gaap Restructuring And Related Cost Cost Incurred To Date
RestructuringAndRelatedCostCostIncurredToDate
877000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
dei Entity Registrant Name
EntityRegistrantName
METABOLIX, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001121702
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34516762 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
594000 USD
CY2012Q4 us-gaap Long Term Investments
LongTermInvestments
2508000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1233000 USD
CY2012Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
165000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1067000 USD
us-gaap Revenue From Grants
RevenueFromGrants
839000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
387000 USD
mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
134000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5984000 USD
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
55000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
131000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
6170000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
343000 USD
CY2013Q2 mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
62000 USD
mblx Research And Development Revenue
ResearchAndDevelopmentRevenue
618000 USD
CY2013Q2 mblx Research And Development Revenue
ResearchAndDevelopmentRevenue
238000 USD
us-gaap Revenue From Grants
RevenueFromGrants
1308000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1611000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
373000 USD
CY2012Q2 mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
89000 USD
CY2013Q2 us-gaap Revenue From Grants
RevenueFromGrants
584000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
822000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
289050000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242032000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
47340000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53510000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11908000 USD
CY2013Q2 us-gaap Short Term Investments
ShortTermInvestments
19770000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
336000 USD
CY2013Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
819000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
884000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
36913000 USD
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
619000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2013Q2 us-gaap Assets
Assets
38714000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
102000 USD
CY2013Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
138000 USD
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
529000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3980000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
137000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
4117000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
345000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
290971000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-59000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-256660000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
34597000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38714000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34306570 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34306570 shares
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34451328 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34451328 shares
CY2012Q2 us-gaap Revenue From Grants
RevenueFromGrants
461000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
20866000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
492000 USD
mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
11051000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7836000 USD
us-gaap Costs And Expenses
CostsAndExpenses
19379000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-38000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2083000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-311000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-203000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-18000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21277000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
75000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1753000 USD
mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
9802000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6734000 USD
us-gaap Costs And Expenses
CostsAndExpenses
18289000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-14641000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
33000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
437000 USD
CY2012Q2 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
5006000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3437000 USD
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
8880000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7957000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1196000 USD
CY2013Q2 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
4945000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3422000 USD
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
9563000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7857000 USD
CY2013Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
12000 USD
CY2012Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
34000 USD
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-23000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20869000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-11000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-27000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14666000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000 USD
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7960000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 USD
CY2013Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7882000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
718000 USD
mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
264000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
362000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2821000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
101000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-675000 USD
mblx Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
-78000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-38562000 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
446000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18143000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
287000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
47935000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
57207000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
8985000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-6000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-9145000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
531000 USD
mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
268000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1677000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-503000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-75000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
263000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
192000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1131000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-345000 USD
mblx Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
-76000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-538000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14294000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
270000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
10580000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
22509000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
11634000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
14000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-2664000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12132000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.85 pure
CY2013Q2 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
1000 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
217000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
25000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-49000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26000 USD
CY2013Q2 mblx Inventory Obsolescence For Raw Material And Finished Goods
InventoryObsolescenceForRawMaterialAndFinishedGoods
271000 USD

Files In Submission

Name View Source Status
0001104659-13-059323-index-headers.html Edgar Link pending
0001104659-13-059323-index.html Edgar Link pending
0001104659-13-059323.txt Edgar Link pending
0001104659-13-059323-xbrl.zip Edgar Link pending
a13-13862_110q.htm Edgar Link pending
a13-13862_1ex10d1.htm Edgar Link pending
a13-13862_1ex10d2.htm Edgar Link pending
a13-13862_1ex31d1.htm Edgar Link pending
a13-13862_1ex31d2.htm Edgar Link pending
a13-13862_1ex32d1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g138621kgi001.jpg Edgar Link pending
g138621kgi002.jpg Edgar Link pending
g138621kii001.jpg Edgar Link pending
g138621kii002.jpg Edgar Link pending
mblx-20130630.xml Edgar Link completed
mblx-20130630.xsd Edgar Link pending
mblx-20130630_cal.xml Edgar Link unprocessable
mblx-20130630_def.xml Edgar Link unprocessable
mblx-20130630_lab.xml Edgar Link unprocessable
mblx-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending